Spasticity in multiple sclerosis;Spasticité et SEP

Revue Neurologique

Volumn 157, Issue 8-9 II, 2001, Pages 1041-1044

  Bussel, B ^a   Remy Neris, O ^a   Mailhan, L ^a  

^a RAYMOND POINCARÉ HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BACLOFEN; BOTULINUM TOXIN;

CONFERENCE PAPER; DISABILITY; HUMAN; MULTIPLE SCLEROSIS; NERVE STIMULATION; NERVE TRANSECTION; NEUROMUSCULAR BLOCKING; PATHOPHYSIOLOGY; SPASTICITY;

DISABILITY EVALUATION; HUMANS; MULTIPLE SCLEROSIS; MUSCLE SPASTICITY; NEUROLOGIC EXAMINATION; NEUROMUSCULAR AGENTS; PROGNOSIS; TREATMENT OUTCOME;

EID: 0034785625     PISSN: 00353787     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (14)

1. Preliminary trial of carisoprodal in multiple sclerosis
2. Intrathecal baclofen administration for control of severe spinal spasticity: Functionnal improvement and long term follow up
3. Disynaptic reciprocal inhibition of ankle extensors in spastic patients
4. Évaluation médico-économique du baclofen intrathécal chez des patients présentants une spasticité chronique sévère
5. Botulinum toxin and spasticity
6. Botulinum toxin (Dysport) treatment of hip adductor spasticity in multiple sclerosis: A prospective, randomised, double blind, placebo controlled, dose ranging study
7. Tizanidine treatment of spasticity: A meta-analysis of controlled, double-blind, comparative studies with baclofen and diazepam
8. Spasticity: Disorder of motor control
9. Gabapentin for relief of upper motor neuron symptoms in multiple sclerosis
10. Treatment of spasticity with repetitive magnetic stimulation; a double-blind placebo-controlled study
11. Continuous intrathecal baclofen for severe spasticity
12. Effect of baclofen on gait in spastic MS patients
13. Medicinal applications of delta-9-tetrahydrocannabinol and marijuana
14. Reciprocal la inhibition in spastic hemiplegia of man